Search
  
Department of Obstetrics and Gynecology

Ortho-Clinical Diagnostics: Blood Samples and the Diagnosis of Preeclampsia

::Download Preeclampsia Brochure

Pregnant Woman
Preeclampsia affects both the mother and the unborn baby

This study is being conducted to help in the development of a test to diagnose a disease known as preeclampsia.

This research study is being conducted by Ortho-Clinical Diagnostics, Inc. (a Johnson & Johnson company).

Preeclampsia is a problem that can occur in some pregnancies, usually in the second half of the pregnancy. It happens more often in women who are pregnant for the first time, carrying more than one baby, those under age 20 and over age 35, and women who had high blood pressure or kidney disease before they became pregnant. At this time, preeclampsia is diagnosed by doctors when pregnant women develop signs and symptoms, such as protein in the urine and high blood pressure.

Learn more about preeclampsia.

Purpose of this Study

The purpose of this study is to collect blood and urine samples at different times during pregnancy and test the samples for certain biomarkers that are found in women with preeclampsia.

Participation in the Study

About 1000 pregnant women will be enrolled in the study in medical centers across the United States and Canada.

If you qualify to take part in the study, the study doctor will collect blood and urine samples at five (5) different times during your pregnancy and at delivery. Samples will be collected at:

  • 10-16 weeks of pregnancy
  • 17-22 weeks of pregnancy
  • 23-27 weeks of pregnancy
  • 28-31 weeks of pregnancy
  • 32-35 weeks of pregnancy
  • Delivery

Compensation

Patients will be compensated for their time and involvement in this study. Please contact the study coordinator for additional information.

How can you help?

If you are interested in finding out more information about this study, please call:

Study Coordinator
Barbara Domings, RN, MBA
(212) 263-8593

Study Doctor
Dr. David Seubert
(212) 263-7021